Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06591741
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-07
Brief Title:
PCA Administration in Prosthetic Joint Infection
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effects of Dietary Protocatechuic Acid PCA on the Function and Structure of Participants With Knee Prosthetic Joint Infection PJI as Measured by Standard Biomarkers
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Determine if dietary protocatechuic acid PCA will affect health biomarkers in patient undergoing revision surgery for a knee prosthetic joint infection
Detailed Description:
Patients who are scheduled to undergo revision surgery for a knee prosthetic joint infection are given PCA prior to surgery for a time period determined by a previous pilot study PCA is then post-operatively until anticoagulation is stopped and then will be resumed for four years post revision surgery Measurement of changes in glucose control immunity will be measured over the first 3 months post-revision and the post-revision reinfection rate over the full 4 years will be compared to a cohort rate
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None